nodes	percent_of_prediction	percent_of_DWPC	metapath
Dofetilide—CYP3A4—Topotecan—lung cancer	0.0643	0.142	CbGbCtD
Dofetilide—CYP3A4—Gefitinib—lung cancer	0.0588	0.13	CbGbCtD
Dofetilide—CYP3A4—Teniposide—lung cancer	0.057	0.126	CbGbCtD
Dofetilide—CYP3A4—Vinorelbine—lung cancer	0.0453	0.1	CbGbCtD
Dofetilide—CYP3A4—Crizotinib—lung cancer	0.0361	0.0796	CbGbCtD
Dofetilide—CYP3A4—Erlotinib—lung cancer	0.0348	0.0768	CbGbCtD
Dofetilide—CYP3A4—Paclitaxel—lung cancer	0.0318	0.0703	CbGbCtD
Dofetilide—CYP3A4—Irinotecan—lung cancer	0.0314	0.0694	CbGbCtD
Dofetilide—CYP3A4—Vinblastine—lung cancer	0.0279	0.0617	CbGbCtD
Dofetilide—CYP3A4—Etoposide—lung cancer	0.0252	0.0556	CbGbCtD
Dofetilide—CYP3A4—Docetaxel—lung cancer	0.023	0.0508	CbGbCtD
Dofetilide—CYP3A4—Doxorubicin—lung cancer	0.0172	0.0379	CbGbCtD
Dofetilide—KCNJ12—Activation of GABAB receptors—ADCY1—lung cancer	0.0078	0.0559	CbGpPWpGaD
Dofetilide—KCNK2—mammary gland—lung cancer	0.00774	0.336	CbGeAlD
Dofetilide—KCNJ12—cardiac atrium—lung cancer	0.00627	0.272	CbGeAlD
Dofetilide—KCNJ12—GABA receptor activation—ADCY1—lung cancer	0.00598	0.0428	CbGpPWpGaD
Dofetilide—KCNJ12—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK3—lung cancer	0.00523	0.0375	CbGpPWpGaD
Dofetilide—KCNJ12—lung—lung cancer	0.00479	0.208	CbGeAlD
Dofetilide—KCNJ12—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB4—lung cancer	0.00427	0.0305	CbGpPWpGaD
Dofetilide—KCNJ12—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—lung cancer	0.00397	0.0284	CbGpPWpGaD
Dofetilide—KCNJ12—Transmission across Chemical Synapses—GRIK3—lung cancer	0.00394	0.0282	CbGpPWpGaD
Dofetilide—Rosiglitazone—CYP2A6—lung cancer	0.00392	0.487	CrCbGaD
Dofetilide—CYP3A4—Felbamate Metabolism—CYP2E1—lung cancer	0.00372	0.0266	CbGpPWpGaD
Dofetilide—KCNJ12—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—lung cancer	0.00323	0.0232	CbGpPWpGaD
Dofetilide—KCNJ12—Transmission across Chemical Synapses—CHRNB4—lung cancer	0.00321	0.023	CbGpPWpGaD
Dofetilide—KCNJ12—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNG11—lung cancer	0.00306	0.0219	CbGpPWpGaD
Dofetilide—KCNJ12—Neuronal System—GRIK3—lung cancer	0.00302	0.0216	CbGpPWpGaD
Dofetilide—KCNJ12—Transmission across Chemical Synapses—CHRNA5—lung cancer	0.00298	0.0214	CbGpPWpGaD
Dofetilide—KCNH2—Hematopoietic Stem Cell Differentiation—CSF3—lung cancer	0.00281	0.0202	CbGpPWpGaD
Dofetilide—KCNJ12—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY1—lung cancer	0.00275	0.0197	CbGpPWpGaD
Dofetilide—KCNJ12—Neuronal System—CHRNB4—lung cancer	0.00246	0.0176	CbGpPWpGaD
Dofetilide—KCNJ12—Transmission across Chemical Synapses—CHRNA3—lung cancer	0.00243	0.0174	CbGpPWpGaD
Dofetilide—KCNJ12—Transmission across Chemical Synapses—GNG11—lung cancer	0.0023	0.0165	CbGpPWpGaD
Dofetilide—KCNJ12—Neuronal System—CHRNA5—lung cancer	0.00229	0.0164	CbGpPWpGaD
Dofetilide—KCNJ12—Transmission across Chemical Synapses—ADCY1—lung cancer	0.00207	0.0148	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—GRIK3—lung cancer	0.00191	0.0137	CbGpPWpGaD
Dofetilide—CYP3A4—Codeine and Morphine Metabolism—ABCC3—lung cancer	0.00188	0.0135	CbGpPWpGaD
Dofetilide—KCNK2—lymph node—lung cancer	0.00187	0.0813	CbGeAlD
Dofetilide—KCNJ12—Neuronal System—CHRNA3—lung cancer	0.00186	0.0133	CbGpPWpGaD
Dofetilide—CYP3A4—Codeine and Morphine Metabolism—UGT1A1—lung cancer	0.00177	0.0127	CbGpPWpGaD
Dofetilide—KCNJ12—Neuronal System—GNG11—lung cancer	0.00176	0.0126	CbGpPWpGaD
Dofetilide—CYP3A4—Benzo(a)pyrene metabolism—AKR1C1—lung cancer	0.00166	0.0119	CbGpPWpGaD
Dofetilide—KCNJ12—Neuronal System—ADCY1—lung cancer	0.00158	0.0113	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—CHRNB4—lung cancer	0.00156	0.0112	CbGpPWpGaD
Dofetilide—Rosiglitazone—ALB—lung cancer	0.00153	0.19	CrCbGaD
Dofetilide—KCNK2—Neuronal System—CHRNA5—lung cancer	0.00145	0.0104	CbGpPWpGaD
Dofetilide—Dronedarone—ALB—lung cancer	0.00133	0.165	CrCbGaD
Dofetilide—Dronedarone—ABCB1—lung cancer	0.00127	0.158	CrCbGaD
Dofetilide—CYP3A4—Xenobiotics—CYP2A7—lung cancer	0.00119	0.00854	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—CHRNA3—lung cancer	0.00118	0.00847	CbGpPWpGaD
Dofetilide—KCNJ12—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—lung cancer	0.00116	0.00832	CbGpPWpGaD
Dofetilide—CYP3A4—Irinotecan Pathway—UGT1A1—lung cancer	0.00113	0.00809	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—GNG11—lung cancer	0.00112	0.00801	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—CHRNB4—lung cancer	0.00105	0.00753	CbGpPWpGaD
Dofetilide—CYP3A4—Aflatoxin B1 metabolism—GSTM1—lung cancer	0.00103	0.0074	CbGpPWpGaD
Dofetilide—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC3—lung cancer	0.00103	0.00737	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—ADCY1—lung cancer	0.00101	0.0072	CbGpPWpGaD
Dofetilide—KCNH2—cardiac atrium—lung cancer	0.000999	0.0434	CbGeAlD
Dofetilide—CYP3A4—Estrogen metabolism—GSTA1—lung cancer	0.000994	0.00712	CbGpPWpGaD
Dofetilide—CYP3A4—Irinotecan Pathway—ABCG2—lung cancer	0.00098	0.00702	CbGpPWpGaD
Dofetilide—KCNJ12—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—lung cancer	0.000974	0.00697	CbGpPWpGaD
Dofetilide—KCNJ12—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—lung cancer	0.000971	0.00695	CbGpPWpGaD
Dofetilide—CYP3A4—Codeine and Morphine Metabolism—ABCB1—lung cancer	0.000957	0.00685	CbGpPWpGaD
Dofetilide—CYP3A4—Estrogen metabolism—UGT1A1—lung cancer	0.000924	0.00662	CbGpPWpGaD
Dofetilide—Acute coronary syndrome—Etoposide—lung cancer	0.000875	0.00232	CcSEcCtD
Dofetilide—KCNJ12—Transmission across Chemical Synapses—BRAF—lung cancer	0.000874	0.00626	CbGpPWpGaD
Dofetilide—Hypertension—Vinorelbine—lung cancer	0.000873	0.00232	CcSEcCtD
Dofetilide—Myocardial infarction—Etoposide—lung cancer	0.00087	0.00231	CcSEcCtD
Dofetilide—Musculoskeletal discomfort—Erlotinib—lung cancer	0.00087	0.00231	CcSEcCtD
Dofetilide—Paraesthesia—Topotecan—lung cancer	0.000866	0.0023	CcSEcCtD
Dofetilide—Insomnia—Erlotinib—lung cancer	0.000863	0.00229	CcSEcCtD
Dofetilide—Chest pain—Vinorelbine—lung cancer	0.000861	0.00229	CcSEcCtD
Dofetilide—Arthralgia—Vinorelbine—lung cancer	0.000861	0.00229	CcSEcCtD
Dofetilide—Dyspnoea—Topotecan—lung cancer	0.00086	0.00228	CcSEcCtD
Dofetilide—Acute coronary syndrome—Paclitaxel—lung cancer	0.000858	0.00228	CcSEcCtD
Dofetilide—Arrhythmia—Irinotecan—lung cancer	0.000856	0.00227	CcSEcCtD
Dofetilide—Myocardial infarction—Paclitaxel—lung cancer	0.000853	0.00227	CcSEcCtD
Dofetilide—Dyspnoea—Erlotinib—lung cancer	0.000851	0.00226	CcSEcCtD
Dofetilide—Pain—Vinblastine—lung cancer	0.000849	0.00226	CcSEcCtD
Dofetilide—Atrioventricular block—Doxorubicin—lung cancer	0.000848	0.00225	CcSEcCtD
Dofetilide—Urinary tract infection—Paclitaxel—lung cancer	0.000846	0.00225	CcSEcCtD
Dofetilide—KCNH2—bone marrow—lung cancer	0.000844	0.0366	CbGeAlD
Dofetilide—Arrhythmia—Gemcitabine—lung cancer	0.000834	0.00221	CcSEcCtD
Dofetilide—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—lung cancer	0.000828	0.00593	CbGpPWpGaD
Dofetilide—Pain—Topotecan—lung cancer	0.000825	0.00219	CcSEcCtD
Dofetilide—Hepatocellular injury—Doxorubicin—lung cancer	0.000823	0.00219	CcSEcCtD
Dofetilide—Ventricular tachycardia—Doxorubicin—lung cancer	0.000823	0.00219	CcSEcCtD
Dofetilide—Rash—Teniposide—lung cancer	0.000821	0.00218	CcSEcCtD
Dofetilide—Dermatitis—Teniposide—lung cancer	0.00082	0.00218	CcSEcCtD
Dofetilide—Pain—Erlotinib—lung cancer	0.000816	0.00217	CcSEcCtD
Dofetilide—Headache—Teniposide—lung cancer	0.000815	0.00217	CcSEcCtD
Dofetilide—Gastrointestinal pain—Vinblastine—lung cancer	0.000812	0.00216	CcSEcCtD
Dofetilide—KCNH2—Neuronal System—GRIK3—lung cancer	0.000811	0.0058	CbGpPWpGaD
Dofetilide—Back pain—Irinotecan—lung cancer	0.000807	0.00214	CcSEcCtD
Dofetilide—Angina pectoris—Docetaxel—lung cancer	0.000806	0.00214	CcSEcCtD
Dofetilide—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—lung cancer	0.000802	0.00574	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—FOXM1—lung cancer	0.000798	0.00571	CbGpPWpGaD
Dofetilide—Bradycardia—Paclitaxel—lung cancer	0.000795	0.00211	CcSEcCtD
Dofetilide—Gastrointestinal pain—Topotecan—lung cancer	0.000789	0.0021	CcSEcCtD
Dofetilide—Back pain—Gemcitabine—lung cancer	0.000786	0.00209	CcSEcCtD
Dofetilide—Abdominal pain—Vinblastine—lung cancer	0.000785	0.00209	CcSEcCtD
Dofetilide—Gastrointestinal pain—Erlotinib—lung cancer	0.00078	0.00207	CcSEcCtD
Dofetilide—Arrhythmia—Cisplatin—lung cancer	0.000777	0.00206	CcSEcCtD
Dofetilide—CYP3A4—Tryptophan metabolism—HSD17B10—lung cancer	0.000775	0.00555	CbGpPWpGaD
Dofetilide—Nausea—Teniposide—lung cancer	0.000773	0.00205	CcSEcCtD
Dofetilide—Oedema peripheral—Paclitaxel—lung cancer	0.00077	0.00204	CcSEcCtD
Dofetilide—Abdominal pain—Topotecan—lung cancer	0.000763	0.00203	CcSEcCtD
Dofetilide—Abdominal pain—Erlotinib—lung cancer	0.000754	0.002	CcSEcCtD
Dofetilide—Musculoskeletal discomfort—Vinorelbine—lung cancer	0.000752	0.002	CcSEcCtD
Dofetilide—Syncope—Irinotecan—lung cancer	0.000748	0.00199	CcSEcCtD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—SOX2—lung cancer	0.000741	0.00531	CbGpPWpGaD
Dofetilide—Paraesthesia—Vinorelbine—lung cancer	0.000741	0.00197	CcSEcCtD
Dofetilide—Dyspnoea—Vinorelbine—lung cancer	0.000736	0.00195	CcSEcCtD
Dofetilide—Loss of consciousness—Irinotecan—lung cancer	0.000733	0.00195	CcSEcCtD
Dofetilide—KCNJ12—Transmission across Chemical Synapses—MDM2—lung cancer	0.000732	0.00524	CbGpPWpGaD
Dofetilide—KCNJ12—Transmission across Chemical Synapses—RAF1—lung cancer	0.00073	0.00523	CbGpPWpGaD
Dofetilide—Cough—Irinotecan—lung cancer	0.000728	0.00193	CcSEcCtD
Dofetilide—Acute coronary syndrome—Docetaxel—lung cancer	0.000727	0.00193	CcSEcCtD
Dofetilide—Myocardial infarction—Docetaxel—lung cancer	0.000723	0.00192	CcSEcCtD
Dofetilide—Hypertension—Irinotecan—lung cancer	0.00072	0.00191	CcSEcCtD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—ALDOA—lung cancer	0.000718	0.00514	CbGpPWpGaD
Dofetilide—Asthenia—Vinblastine—lung cancer	0.000712	0.00189	CcSEcCtD
Dofetilide—Cough—Gemcitabine—lung cancer	0.000709	0.00188	CcSEcCtD
Dofetilide—Pain—Vinorelbine—lung cancer	0.000706	0.00187	CcSEcCtD
Dofetilide—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—lung cancer	0.000704	0.00504	CbGpPWpGaD
Dofetilide—Cerebrovascular accident—Methotrexate—lung cancer	0.000704	0.00187	CcSEcCtD
Dofetilide—Hypertension—Gemcitabine—lung cancer	0.000701	0.00186	CcSEcCtD
Dofetilide—Arrhythmia—Paclitaxel—lung cancer	0.000698	0.00185	CcSEcCtD
Dofetilide—CYP3A4—Xenobiotics—CYP2A6—lung cancer	0.000693	0.00496	CbGpPWpGaD
Dofetilide—Asthenia—Topotecan—lung cancer	0.000692	0.00184	CcSEcCtD
Dofetilide—Arthralgia—Gemcitabine—lung cancer	0.000692	0.00184	CcSEcCtD
Dofetilide—Chest pain—Gemcitabine—lung cancer	0.000692	0.00184	CcSEcCtD
Dofetilide—Asthenia—Erlotinib—lung cancer	0.000685	0.00182	CcSEcCtD
Dofetilide—Oedema—Irinotecan—lung cancer	0.000681	0.00181	CcSEcCtD
Dofetilide—Diarrhoea—Vinblastine—lung cancer	0.000679	0.00181	CcSEcCtD
Dofetilide—Gastrointestinal pain—Vinorelbine—lung cancer	0.000675	0.00179	CcSEcCtD
Dofetilide—Back pain—Etoposide—lung cancer	0.000671	0.00178	CcSEcCtD
Dofetilide—KCNJ12—Neuronal System—BRAF—lung cancer	0.00067	0.00479	CbGpPWpGaD
Dofetilide—Shock—Irinotecan—lung cancer	0.00067	0.00178	CcSEcCtD
Dofetilide—CYP3A4—Tamoxifen metabolism—CYP2A6—lung cancer	0.000666	0.00477	CbGpPWpGaD
Dofetilide—Oedema—Gemcitabine—lung cancer	0.000663	0.00176	CcSEcCtD
Dofetilide—KCNH2—Neuronal System—CHRNB4—lung cancer	0.000661	0.00473	CbGpPWpGaD
Dofetilide—Diarrhoea—Topotecan—lung cancer	0.00066	0.00175	CcSEcCtD
Dofetilide—Hyperhidrosis—Irinotecan—lung cancer	0.000658	0.00175	CcSEcCtD
Dofetilide—Back pain—Paclitaxel—lung cancer	0.000658	0.00175	CcSEcCtD
Dofetilide—Dizziness—Vinblastine—lung cancer	0.000657	0.00174	CcSEcCtD
Dofetilide—Diarrhoea—Erlotinib—lung cancer	0.000653	0.00173	CcSEcCtD
Dofetilide—Abdominal pain—Vinorelbine—lung cancer	0.000652	0.00173	CcSEcCtD
Dofetilide—Oedema peripheral—Docetaxel—lung cancer	0.000652	0.00173	CcSEcCtD
Dofetilide—CYP3A4—Constitutive Androstane Receptor Pathway—GSTA2—lung cancer	0.00065	0.00466	CbGpPWpGaD
Dofetilide—Anxiety—Cisplatin—lung cancer	0.000642	0.00171	CcSEcCtD
Dofetilide—Hyperhidrosis—Gemcitabine—lung cancer	0.000641	0.0017	CcSEcCtD
Dofetilide—Dizziness—Topotecan—lung cancer	0.000638	0.00169	CcSEcCtD
Dofetilide—CYP3A4—Estrogen metabolism—NQO1—lung cancer	0.000634	0.00454	CbGpPWpGaD
Dofetilide—Dizziness—Erlotinib—lung cancer	0.000631	0.00168	CcSEcCtD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—TF—lung cancer	0.00063	0.00451	CbGpPWpGaD
Dofetilide—Headache—Vinblastine—lung cancer	0.000622	0.00165	CcSEcCtD
Dofetilide—Angioedema—Paclitaxel—lung cancer	0.000621	0.00165	CcSEcCtD
Dofetilide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC3—lung cancer	0.000621	0.00444	CbGpPWpGaD
Dofetilide—Oedema—Cisplatin—lung cancer	0.000618	0.00164	CcSEcCtD
Dofetilide—Insomnia—Irinotecan—lung cancer	0.000616	0.00164	CcSEcCtD
Dofetilide—KCNH2—Neuronal System—CHRNA5—lung cancer	0.000614	0.0044	CbGpPWpGaD
Dofetilide—Cardiac failure—Doxorubicin—lung cancer	0.000612	0.00163	CcSEcCtD
Dofetilide—Paraesthesia—Irinotecan—lung cancer	0.000611	0.00162	CcSEcCtD
Dofetilide—Syncope—Paclitaxel—lung cancer	0.00061	0.00162	CcSEcCtD
Dofetilide—Loss of consciousness—Etoposide—lung cancer	0.00061	0.00162	CcSEcCtD
Dofetilide—Cerebrovascular accident—Doxorubicin—lung cancer	0.00061	0.00162	CcSEcCtD
Dofetilide—Rash—Topotecan—lung cancer	0.000608	0.00162	CcSEcCtD
Dofetilide—Dermatitis—Topotecan—lung cancer	0.000608	0.00161	CcSEcCtD
Dofetilide—Dyspnoea—Irinotecan—lung cancer	0.000607	0.00161	CcSEcCtD
Dofetilide—Cough—Etoposide—lung cancer	0.000605	0.00161	CcSEcCtD
Dofetilide—Headache—Topotecan—lung cancer	0.000604	0.00161	CcSEcCtD
Dofetilide—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.000604	0.0016	CcSEcCtD
Dofetilide—Rash—Erlotinib—lung cancer	0.000602	0.0016	CcSEcCtD
Dofetilide—Dermatitis—Erlotinib—lung cancer	0.000601	0.0016	CcSEcCtD
Dofetilide—Palpitations—Paclitaxel—lung cancer	0.000601	0.0016	CcSEcCtD
Dofetilide—Insomnia—Gemcitabine—lung cancer	0.0006	0.00159	CcSEcCtD
Dofetilide—Hypertension—Etoposide—lung cancer	0.000599	0.00159	CcSEcCtD
Dofetilide—Headache—Erlotinib—lung cancer	0.000598	0.00159	CcSEcCtD
Dofetilide—Loss of consciousness—Paclitaxel—lung cancer	0.000598	0.00159	CcSEcCtD
Dofetilide—Hyperhidrosis—Cisplatin—lung cancer	0.000597	0.00159	CcSEcCtD
Dofetilide—Paraesthesia—Gemcitabine—lung cancer	0.000595	0.00158	CcSEcCtD
Dofetilide—Cough—Paclitaxel—lung cancer	0.000593	0.00158	CcSEcCtD
Dofetilide—Asthenia—Vinorelbine—lung cancer	0.000592	0.00157	CcSEcCtD
Dofetilide—Arrhythmia—Docetaxel—lung cancer	0.000592	0.00157	CcSEcCtD
Dofetilide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC3—lung cancer	0.000591	0.00423	CbGpPWpGaD
Dofetilide—Dyspnoea—Gemcitabine—lung cancer	0.000591	0.00157	CcSEcCtD
Dofetilide—Chest pain—Etoposide—lung cancer	0.000591	0.00157	CcSEcCtD
Dofetilide—Nausea—Vinblastine—lung cancer	0.00059	0.00157	CcSEcCtD
Dofetilide—CYP3A4—Xenobiotics—CYP2E1—lung cancer	0.000589	0.00422	CbGpPWpGaD
Dofetilide—Migraine—Doxorubicin—lung cancer	0.000588	0.00156	CcSEcCtD
Dofetilide—Hypertension—Paclitaxel—lung cancer	0.000587	0.00156	CcSEcCtD
Dofetilide—CYP3A4—Constitutive Androstane Receptor Pathway—UGT1A1—lung cancer	0.000583	0.00418	CbGpPWpGaD
Dofetilide—Pain—Irinotecan—lung cancer	0.000582	0.00155	CcSEcCtD
Dofetilide—Arthralgia—Paclitaxel—lung cancer	0.000579	0.00154	CcSEcCtD
Dofetilide—Chest pain—Paclitaxel—lung cancer	0.000579	0.00154	CcSEcCtD
Dofetilide—Anxiety—Paclitaxel—lung cancer	0.000577	0.00153	CcSEcCtD
Dofetilide—Nausea—Topotecan—lung cancer	0.000573	0.00152	CcSEcCtD
Dofetilide—Cardiac arrest—Doxorubicin—lung cancer	0.000568	0.00151	CcSEcCtD
Dofetilide—Pain—Gemcitabine—lung cancer	0.000567	0.00151	CcSEcCtD
Dofetilide—Nausea—Erlotinib—lung cancer	0.000567	0.00151	CcSEcCtD
Dofetilide—CYP3A4—Tamoxifen metabolism—CYP2E1—lung cancer	0.000566	0.00406	CbGpPWpGaD
Dofetilide—Diarrhoea—Vinorelbine—lung cancer	0.000565	0.0015	CcSEcCtD
Dofetilide—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000563	0.0015	CcSEcCtD
Dofetilide—KCNJ12—Neuronal System—MDM2—lung cancer	0.000561	0.00402	CbGpPWpGaD
Dofetilide—KCNJ12—Neuronal System—RAF1—lung cancer	0.000559	0.004	CbGpPWpGaD
Dofetilide—Back pain—Docetaxel—lung cancer	0.000558	0.00148	CcSEcCtD
Dofetilide—Gastrointestinal pain—Irinotecan—lung cancer	0.000557	0.00148	CcSEcCtD
Dofetilide—Oedema—Paclitaxel—lung cancer	0.000555	0.00147	CcSEcCtD
Dofetilide—Paraesthesia—Cisplatin—lung cancer	0.000555	0.00147	CcSEcCtD
Dofetilide—Dyspnoea—Cisplatin—lung cancer	0.000551	0.00146	CcSEcCtD
Dofetilide—Hyperhidrosis—Etoposide—lung cancer	0.000547	0.00145	CcSEcCtD
Dofetilide—Shock—Paclitaxel—lung cancer	0.000546	0.00145	CcSEcCtD
Dofetilide—Dizziness—Vinorelbine—lung cancer	0.000546	0.00145	CcSEcCtD
Dofetilide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—lung cancer	0.000541	0.00387	CbGpPWpGaD
Dofetilide—Abdominal pain—Irinotecan—lung cancer	0.000538	0.00143	CcSEcCtD
Dofetilide—Hyperhidrosis—Paclitaxel—lung cancer	0.000537	0.00143	CcSEcCtD
Dofetilide—KCNJ12—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—lung cancer	0.000535	0.00383	CbGpPWpGaD
Dofetilide—Pain—Cisplatin—lung cancer	0.000528	0.0014	CcSEcCtD
Dofetilide—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—lung cancer	0.000524	0.00375	CbGpPWpGaD
Dofetilide—KCNH2—lymph node—lung cancer	0.000523	0.0227	CbGeAlD
Dofetilide—Rash—Vinorelbine—lung cancer	0.00052	0.00138	CcSEcCtD
Dofetilide—Dermatitis—Vinorelbine—lung cancer	0.00052	0.00138	CcSEcCtD
Dofetilide—Headache—Vinorelbine—lung cancer	0.000517	0.00137	CcSEcCtD
Dofetilide—Syncope—Docetaxel—lung cancer	0.000517	0.00137	CcSEcCtD
Dofetilide—Influenza—Doxorubicin—lung cancer	0.000516	0.00137	CcSEcCtD
Dofetilide—Sweating—Methotrexate—lung cancer	0.00051	0.00135	CcSEcCtD
Dofetilide—Palpitations—Docetaxel—lung cancer	0.000509	0.00135	CcSEcCtD
Dofetilide—Paraesthesia—Etoposide—lung cancer	0.000508	0.00135	CcSEcCtD
Dofetilide—Loss of consciousness—Docetaxel—lung cancer	0.000507	0.00135	CcSEcCtD
Dofetilide—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—lung cancer	0.000506	0.00362	CbGpPWpGaD
Dofetilide—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000506	0.00134	CcSEcCtD
Dofetilide—Dyspnoea—Etoposide—lung cancer	0.000505	0.00134	CcSEcCtD
Dofetilide—Cough—Docetaxel—lung cancer	0.000503	0.00134	CcSEcCtD
Dofetilide—Angina pectoris—Doxorubicin—lung cancer	0.000503	0.00134	CcSEcCtD
Dofetilide—Insomnia—Paclitaxel—lung cancer	0.000502	0.00133	CcSEcCtD
Dofetilide—KCNH2—Neuronal System—CHRNA3—lung cancer	0.000501	0.00359	CbGpPWpGaD
Dofetilide—Paraesthesia—Paclitaxel—lung cancer	0.000498	0.00132	CcSEcCtD
Dofetilide—Hypertension—Docetaxel—lung cancer	0.000498	0.00132	CcSEcCtD
Dofetilide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—lung cancer	0.000495	0.00355	CbGpPWpGaD
Dofetilide—Dyspnoea—Paclitaxel—lung cancer	0.000495	0.00131	CcSEcCtD
Dofetilide—Chest pain—Docetaxel—lung cancer	0.000491	0.0013	CcSEcCtD
Dofetilide—Arthralgia—Docetaxel—lung cancer	0.000491	0.0013	CcSEcCtD
Dofetilide—Nausea—Vinorelbine—lung cancer	0.00049	0.0013	CcSEcCtD
Dofetilide—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—lung cancer	0.000489	0.0035	CbGpPWpGaD
Dofetilide—Asthenia—Irinotecan—lung cancer	0.000488	0.0013	CcSEcCtD
Dofetilide—CYP3A4—Estrogen metabolism—GSTM1—lung cancer	0.000486	0.00348	CbGpPWpGaD
Dofetilide—Pain—Etoposide—lung cancer	0.000484	0.00129	CcSEcCtD
Dofetilide—Asthenia—Gemcitabine—lung cancer	0.000476	0.00126	CcSEcCtD
Dofetilide—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—lung cancer	0.000476	0.0034	CbGpPWpGaD
Dofetilide—Pain—Paclitaxel—lung cancer	0.000475	0.00126	CcSEcCtD
Dofetilide—KCNH2—Neuronal System—GNG11—lung cancer	0.000474	0.00339	CbGpPWpGaD
Dofetilide—Oedema—Docetaxel—lung cancer	0.00047	0.00125	CcSEcCtD
Dofetilide—Diarrhoea—Irinotecan—lung cancer	0.000466	0.00124	CcSEcCtD
Dofetilide—Gastrointestinal pain—Etoposide—lung cancer	0.000463	0.00123	CcSEcCtD
Dofetilide—Shock—Docetaxel—lung cancer	0.000463	0.00123	CcSEcCtD
Dofetilide—CYP3A4—Estrogen metabolism—CYP1A1—lung cancer	0.00046	0.0033	CbGpPWpGaD
Dofetilide—Gastrointestinal pain—Paclitaxel—lung cancer	0.000454	0.00121	CcSEcCtD
Dofetilide—Diarrhoea—Gemcitabine—lung cancer	0.000454	0.00121	CcSEcCtD
Dofetilide—Dizziness—Irinotecan—lung cancer	0.00045	0.0012	CcSEcCtD
Dofetilide—Abdominal pain—Etoposide—lung cancer	0.000448	0.00119	CcSEcCtD
Dofetilide—Urinary tract infection—Doxorubicin—lung cancer	0.000447	0.00119	CcSEcCtD
Dofetilide—Asthenia—Cisplatin—lung cancer	0.000443	0.00118	CcSEcCtD
Dofetilide—Sweating—Doxorubicin—lung cancer	0.000441	0.00117	CcSEcCtD
Dofetilide—CYP3A4—Irinotecan Pathway—APC—lung cancer	0.000441	0.00316	CbGpPWpGaD
Dofetilide—Abdominal pain—Paclitaxel—lung cancer	0.000439	0.00117	CcSEcCtD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—AVP—lung cancer	0.000437	0.00313	CbGpPWpGaD
Dofetilide—Rash—Irinotecan—lung cancer	0.000429	0.00114	CcSEcCtD
Dofetilide—Dermatitis—Irinotecan—lung cancer	0.000429	0.00114	CcSEcCtD
Dofetilide—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000429	0.00114	CcSEcCtD
Dofetilide—Headache—Irinotecan—lung cancer	0.000426	0.00113	CcSEcCtD
Dofetilide—KCNH2—Neuronal System—ADCY1—lung cancer	0.000426	0.00305	CbGpPWpGaD
Dofetilide—Insomnia—Docetaxel—lung cancer	0.000426	0.00113	CcSEcCtD
Dofetilide—KCNK2—Neuronal System—BRAF—lung cancer	0.000425	0.00305	CbGpPWpGaD
Dofetilide—CYP3A4—Xenobiotics—CYP1A1—lung cancer	0.000423	0.00303	CbGpPWpGaD
Dofetilide—Diarrhoea—Cisplatin—lung cancer	0.000423	0.00112	CcSEcCtD
Dofetilide—Paraesthesia—Docetaxel—lung cancer	0.000422	0.00112	CcSEcCtD
Dofetilide—Bradycardia—Doxorubicin—lung cancer	0.000421	0.00112	CcSEcCtD
Dofetilide—Dyspnoea—Docetaxel—lung cancer	0.000419	0.00111	CcSEcCtD
Dofetilide—Rash—Gemcitabine—lung cancer	0.000418	0.00111	CcSEcCtD
Dofetilide—Dermatitis—Gemcitabine—lung cancer	0.000418	0.00111	CcSEcCtD
Dofetilide—Headache—Gemcitabine—lung cancer	0.000415	0.0011	CcSEcCtD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—HES1—lung cancer	0.000413	0.00296	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—IL10—lung cancer	0.000411	0.00294	CbGpPWpGaD
Dofetilide—Oedema peripheral—Doxorubicin—lung cancer	0.000407	0.00108	CcSEcCtD
Dofetilide—CYP3A4—Tamoxifen metabolism—CYP1A1—lung cancer	0.000407	0.00291	CbGpPWpGaD
Dofetilide—Asthenia—Etoposide—lung cancer	0.000406	0.00108	CcSEcCtD
Dofetilide—Nausea—Irinotecan—lung cancer	0.000404	0.00107	CcSEcCtD
Dofetilide—Pain—Docetaxel—lung cancer	0.000402	0.00107	CcSEcCtD
Dofetilide—KCNJ12—Transmission across Chemical Synapses—HRAS—lung cancer	0.000402	0.00288	CbGpPWpGaD
Dofetilide—Back pain—Methotrexate—lung cancer	0.000402	0.00107	CcSEcCtD
Dofetilide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—lung cancer	0.000401	0.00287	CbGpPWpGaD
Dofetilide—Asthenia—Paclitaxel—lung cancer	0.000398	0.00106	CcSEcCtD
Dofetilide—Nausea—Gemcitabine—lung cancer	0.000394	0.00105	CcSEcCtD
Dofetilide—Rash—Cisplatin—lung cancer	0.00039	0.00104	CcSEcCtD
Dofetilide—Dermatitis—Cisplatin—lung cancer	0.000389	0.00103	CcSEcCtD
Dofetilide—Diarrhoea—Etoposide—lung cancer	0.000387	0.00103	CcSEcCtD
Dofetilide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—lung cancer	0.000385	0.00276	CbGpPWpGaD
Dofetilide—Gastrointestinal pain—Docetaxel—lung cancer	0.000385	0.00102	CcSEcCtD
Dofetilide—Diarrhoea—Paclitaxel—lung cancer	0.00038	0.00101	CcSEcCtD
Dofetilide—KCNH2—Hematopoietic Stem Cell Differentiation—IL6—lung cancer	0.000375	0.00268	CbGpPWpGaD
Dofetilide—Dizziness—Etoposide—lung cancer	0.000374	0.000995	CcSEcCtD
Dofetilide—Abdominal pain—Docetaxel—lung cancer	0.000372	0.000988	CcSEcCtD
Dofetilide—Arrhythmia—Doxorubicin—lung cancer	0.000369	0.000981	CcSEcCtD
Dofetilide—Dizziness—Paclitaxel—lung cancer	0.000367	0.000975	CcSEcCtD
Dofetilide—Nausea—Cisplatin—lung cancer	0.000367	0.000975	CcSEcCtD
Dofetilide—Cough—Methotrexate—lung cancer	0.000363	0.000963	CcSEcCtD
Dofetilide—Rash—Etoposide—lung cancer	0.000357	0.000948	CcSEcCtD
Dofetilide—Dermatitis—Etoposide—lung cancer	0.000357	0.000947	CcSEcCtD
Dofetilide—KCNK2—Neuronal System—MDM2—lung cancer	0.000356	0.00255	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—RAF1—lung cancer	0.000355	0.00254	CbGpPWpGaD
Dofetilide—Headache—Etoposide—lung cancer	0.000355	0.000942	CcSEcCtD
Dofetilide—Arthralgia—Methotrexate—lung cancer	0.000354	0.00094	CcSEcCtD
Dofetilide—Chest pain—Methotrexate—lung cancer	0.000354	0.00094	CcSEcCtD
Dofetilide—Rash—Paclitaxel—lung cancer	0.00035	0.00093	CcSEcCtD
Dofetilide—Dermatitis—Paclitaxel—lung cancer	0.00035	0.000929	CcSEcCtD
Dofetilide—Back pain—Doxorubicin—lung cancer	0.000348	0.000925	CcSEcCtD
Dofetilide—Headache—Paclitaxel—lung cancer	0.000348	0.000924	CcSEcCtD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—HIF1A—lung cancer	0.000346	0.00248	CbGpPWpGaD
Dofetilide—Asthenia—Docetaxel—lung cancer	0.000338	0.000897	CcSEcCtD
Dofetilide—Nausea—Etoposide—lung cancer	0.000336	0.000893	CcSEcCtD
Dofetilide—Nausea—Paclitaxel—lung cancer	0.00033	0.000876	CcSEcCtD
Dofetilide—Hyperhidrosis—Methotrexate—lung cancer	0.000328	0.000871	CcSEcCtD
Dofetilide—Syncope—Doxorubicin—lung cancer	0.000323	0.000857	CcSEcCtD
Dofetilide—Diarrhoea—Docetaxel—lung cancer	0.000322	0.000855	CcSEcCtD
Dofetilide—Palpitations—Doxorubicin—lung cancer	0.000318	0.000845	CcSEcCtD
Dofetilide—Loss of consciousness—Doxorubicin—lung cancer	0.000316	0.00084	CcSEcCtD
Dofetilide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—lung cancer	0.000316	0.00226	CbGpPWpGaD
Dofetilide—Cough—Doxorubicin—lung cancer	0.000314	0.000834	CcSEcCtD
Dofetilide—Dizziness—Docetaxel—lung cancer	0.000311	0.000827	CcSEcCtD
Dofetilide—Hypertension—Doxorubicin—lung cancer	0.000311	0.000825	CcSEcCtD
Dofetilide—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000309	0.000821	CcSEcCtD
Dofetilide—KCNJ12—Neuronal System—HRAS—lung cancer	0.000308	0.0022	CbGpPWpGaD
Dofetilide—Insomnia—Methotrexate—lung cancer	0.000307	0.000815	CcSEcCtD
Dofetilide—Chest pain—Doxorubicin—lung cancer	0.000306	0.000814	CcSEcCtD
Dofetilide—Arthralgia—Doxorubicin—lung cancer	0.000306	0.000814	CcSEcCtD
Dofetilide—Anxiety—Doxorubicin—lung cancer	0.000305	0.000811	CcSEcCtD
Dofetilide—Paraesthesia—Methotrexate—lung cancer	0.000304	0.000809	CcSEcCtD
Dofetilide—CYP3A4—Tryptophan metabolism—CYP2E1—lung cancer	0.000302	0.00217	CbGpPWpGaD
Dofetilide—Dyspnoea—Methotrexate—lung cancer	0.000302	0.000803	CcSEcCtD
Dofetilide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—lung cancer	0.000301	0.00215	CbGpPWpGaD
Dofetilide—Rash—Docetaxel—lung cancer	0.000297	0.000788	CcSEcCtD
Dofetilide—Dermatitis—Docetaxel—lung cancer	0.000296	0.000787	CcSEcCtD
Dofetilide—Headache—Docetaxel—lung cancer	0.000295	0.000783	CcSEcCtD
Dofetilide—Oedema—Doxorubicin—lung cancer	0.000294	0.00078	CcSEcCtD
Dofetilide—Pain—Methotrexate—lung cancer	0.00029	0.00077	CcSEcCtD
Dofetilide—Shock—Doxorubicin—lung cancer	0.000289	0.000767	CcSEcCtD
Dofetilide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—lung cancer	0.000288	0.00206	CbGpPWpGaD
Dofetilide—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—lung cancer	0.000284	0.00203	CbGpPWpGaD
Dofetilide—Hyperhidrosis—Doxorubicin—lung cancer	0.000284	0.000754	CcSEcCtD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—IL6R—lung cancer	0.000283	0.00203	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—CREBBP—lung cancer	0.000283	0.00202	CbGpPWpGaD
Dofetilide—Nausea—Docetaxel—lung cancer	0.000279	0.000742	CcSEcCtD
Dofetilide—Gastrointestinal pain—Methotrexate—lung cancer	0.000277	0.000737	CcSEcCtD
Dofetilide—Abdominal pain—Methotrexate—lung cancer	0.000268	0.000712	CcSEcCtD
Dofetilide—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000268	0.000711	CcSEcCtD
Dofetilide—Insomnia—Doxorubicin—lung cancer	0.000266	0.000706	CcSEcCtD
Dofetilide—Paraesthesia—Doxorubicin—lung cancer	0.000264	0.0007	CcSEcCtD
Dofetilide—Dyspnoea—Doxorubicin—lung cancer	0.000262	0.000695	CcSEcCtD
Dofetilide—Pain—Doxorubicin—lung cancer	0.000251	0.000667	CcSEcCtD
Dofetilide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—lung cancer	0.000245	0.00175	CbGpPWpGaD
Dofetilide—Asthenia—Methotrexate—lung cancer	0.000243	0.000646	CcSEcCtD
Dofetilide—CYP3A4—Tryptophan metabolism—CAT—lung cancer	0.000243	0.00174	CbGpPWpGaD
Dofetilide—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—lung cancer	0.000241	0.00173	CbGpPWpGaD
Dofetilide—Gastrointestinal pain—Doxorubicin—lung cancer	0.00024	0.000638	CcSEcCtD
Dofetilide—CYP3A4—Biological oxidations—CNDP2—lung cancer	0.000236	0.00169	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—GSTM2—lung cancer	0.000236	0.00169	CbGpPWpGaD
Dofetilide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—lung cancer	0.000233	0.00167	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—GSTM2—lung cancer	0.000233	0.00166	CbGpPWpGaD
Dofetilide—Abdominal pain—Doxorubicin—lung cancer	0.000232	0.000617	CcSEcCtD
Dofetilide—Diarrhoea—Methotrexate—lung cancer	0.000232	0.000616	CcSEcCtD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—CXCL8—lung cancer	0.000225	0.00161	CbGpPWpGaD
Dofetilide—Dizziness—Methotrexate—lung cancer	0.000224	0.000596	CcSEcCtD
Dofetilide—CYP3A4—Tryptophan metabolism—CYP1A1—lung cancer	0.000217	0.00156	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—CASP3—lung cancer	0.000215	0.00154	CbGpPWpGaD
Dofetilide—Rash—Methotrexate—lung cancer	0.000214	0.000568	CcSEcCtD
Dofetilide—Dermatitis—Methotrexate—lung cancer	0.000214	0.000567	CcSEcCtD
Dofetilide—CYP3A4—Biological oxidations—CYP2A7—lung cancer	0.000213	0.00153	CbGpPWpGaD
Dofetilide—Headache—Methotrexate—lung cancer	0.000212	0.000564	CcSEcCtD
Dofetilide—Asthenia—Doxorubicin—lung cancer	0.000211	0.00056	CcSEcCtD
Dofetilide—CYP3A4—Metapathway biotransformation—CYP2A7—lung cancer	0.00021	0.00151	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—JUN—lung cancer	0.000209	0.0015	CbGpPWpGaD
Dofetilide—Nausea—Methotrexate—lung cancer	0.000201	0.000535	CcSEcCtD
Dofetilide—Diarrhoea—Doxorubicin—lung cancer	0.000201	0.000534	CcSEcCtD
Dofetilide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—lung cancer	0.000198	0.00142	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—HRAS—lung cancer	0.000196	0.0014	CbGpPWpGaD
Dofetilide—Dizziness—Doxorubicin—lung cancer	0.000194	0.000516	CcSEcCtD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—EP300—lung cancer	0.000193	0.00138	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—GSTA3—lung cancer	0.00019	0.00136	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—GSTA3—lung cancer	0.000187	0.00134	CbGpPWpGaD
Dofetilide—Rash—Doxorubicin—lung cancer	0.000185	0.000492	CcSEcCtD
Dofetilide—Dermatitis—Doxorubicin—lung cancer	0.000185	0.000491	CcSEcCtD
Dofetilide—Headache—Doxorubicin—lung cancer	0.000184	0.000489	CcSEcCtD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—VEGFA—lung cancer	0.000182	0.00131	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—BRAF—lung cancer	0.00018	0.00129	CbGpPWpGaD
Dofetilide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	0.000176	0.00126	CbGpPWpGaD
Dofetilide—Nausea—Doxorubicin—lung cancer	0.000174	0.000463	CcSEcCtD
Dofetilide—CYP3A4—Biological oxidations—GSTA4—lung cancer	0.000174	0.00124	CbGpPWpGaD
Dofetilide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—lung cancer	0.000173	0.00124	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—GSTA4—lung cancer	0.000171	0.00123	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—GSTA2—lung cancer	0.000169	0.00121	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—GSTA1—lung cancer	0.000163	0.00117	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—AKR1C1—lung cancer	0.000154	0.00111	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—UGT1A1—lung cancer	0.000152	0.00109	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—MDM2—lung cancer	0.000151	0.00108	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—RAF1—lung cancer	0.00015	0.00108	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—UGT1A1—lung cancer	0.00015	0.00107	CbGpPWpGaD
Dofetilide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	0.000142	0.00102	CbGpPWpGaD
Dofetilide—CYP3A4—Tryptophan metabolism—MDM2—lung cancer	0.000134	0.00096	CbGpPWpGaD
Dofetilide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	0.000131	0.000938	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—HPGDS—lung cancer	0.000129	0.000925	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—IL6—lung cancer	0.000126	0.000903	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—GSTT1—lung cancer	0.000125	0.000897	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—CYP2A6—lung cancer	0.000124	0.000887	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—GCLC—lung cancer	0.000124	0.000887	CbGpPWpGaD
Dofetilide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—lung cancer	0.000106	0.00076	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—CYP2E1—lung cancer	0.000105	0.000754	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—CYP2E1—lung cancer	0.000104	0.000744	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—GSTP1—lung cancer	8.69e-05	0.000622	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	8.57e-05	0.000613	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—HRAS—lung cancer	8.28e-05	0.000593	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—GSTM1—lung cancer	7.98e-05	0.000571	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	7.87e-05	0.000564	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—CYP1A1—lung cancer	7.57e-05	0.000542	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	7.46e-05	0.000534	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—COL4A3BP—lung cancer	6.66e-05	0.000476	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—AZIN2—lung cancer	6.66e-05	0.000476	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ATP5H—lung cancer	5.66e-05	0.000405	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—POMC—lung cancer	5.64e-05	0.000404	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PLBD1—lung cancer	5.04e-05	0.000361	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—HSD17B10—lung cancer	4.61e-05	0.00033	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CKB—lung cancer	4.29e-05	0.000307	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GSTM2—lung cancer	4.03e-05	0.000289	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CNDP2—lung cancer	4.03e-05	0.000289	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—MTMR3—lung cancer	3.92e-05	0.000281	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PGAM1—lung cancer	3.82e-05	0.000274	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CYP2A7—lung cancer	3.65e-05	0.000261	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—SDC4—lung cancer	3.57e-05	0.000255	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GSTA3—lung cancer	3.25e-05	0.000233	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—RRM1—lung cancer	3.25e-05	0.000233	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—B4GALT5—lung cancer	3.06e-05	0.000219	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GSTA4—lung cancer	2.97e-05	0.000213	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GSTA2—lung cancer	2.9e-05	0.000207	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GSTA1—lung cancer	2.8e-05	0.0002	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ABCC3—lung cancer	2.76e-05	0.000198	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—AKR1C1—lung cancer	2.68e-05	0.000192	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—UGT1A1—lung cancer	2.6e-05	0.000186	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GNG11—lung cancer	2.51e-05	0.000179	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ALDOA—lung cancer	2.39e-05	0.000171	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—NCOA3—lung cancer	2.32e-05	0.000166	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ADCY1—lung cancer	2.25e-05	0.000161	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ABCG2—lung cancer	2.25e-05	0.000161	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ENO2—lung cancer	2.21e-05	0.000158	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—HPGDS—lung cancer	2.21e-05	0.000158	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PPP2R1B—lung cancer	2.2e-05	0.000157	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GSTT1—lung cancer	2.14e-05	0.000153	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CYP2A6—lung cancer	2.12e-05	0.000152	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GCLC—lung cancer	2.12e-05	0.000152	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ENO1—lung cancer	2.01e-05	0.000144	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CYP2E1—lung cancer	1.8e-05	0.000129	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—NQO1—lung cancer	1.78e-05	0.000127	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—STK11—lung cancer	1.61e-05	0.000115	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GSTP1—lung cancer	1.49e-05	0.000106	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CAT—lung cancer	1.45e-05	0.000103	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ABCB1—lung cancer	1.41e-05	0.000101	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—TYMS—lung cancer	1.38e-05	9.89e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GSTM1—lung cancer	1.36e-05	9.77e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CYP1A1—lung cancer	1.29e-05	9.26e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ERCC2—lung cancer	1.28e-05	9.19e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—APOA1—lung cancer	1.11e-05	7.95e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PIK3CG—lung cancer	1.01e-05	7.26e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—POMC—lung cancer	9.65e-06	6.91e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CREBBP—lung cancer	9.4e-06	6.73e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PIK3CD—lung cancer	8.91e-06	6.38e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ALB—lung cancer	8.8e-06	6.3e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PIK3CB—lung cancer	7.77e-06	5.56e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PTGS2—lung cancer	7.7e-06	5.51e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PTEN—lung cancer	6.71e-06	4.8e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—EP300—lung cancer	6.4e-06	4.58e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PIK3CA—lung cancer	4.73e-06	3.39e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—AKT1—lung cancer	3.87e-06	2.77e-05	CbGpPWpGaD
